NP / PA
Odom, Carla
Odom, Carla was paid $97K by Medicaid between Oct 2022 and Dec 2024, across 13 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoODOM, CARLA
KOKOMO, MS 39643
KOKOMO, MS 39643
33aNPI1043827900assigned 09/24/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$97K
24GClaims3,879
24DCodes billed13
24AFirst – last monthOct 2022 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Mississippi
Rank by total paid#71 of 206
Median peer was paid$22K
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 188 | $948.42 | |
| 2023 | 2,388 | $54K | |
| 2024incomplete | 1,303 | $42K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 1,375 | 1,062 | $53K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 470 | 394 | $23K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.7% | 306 | 261 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.1% | 964 | 398 | $6K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.5% | 44 | 40 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 364 | 285 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 89 | 83 | $2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 73 | 39 | $668.25 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 135 | 71 | $398.76 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | 14 | $62.42 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | 12 | $8.02 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | 12 | $0.58 |
1 more codes
| 36416 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.